Description
+ Include: videos + file sub vtt + pdf, size: GB
+ Target Audience: oncologists, surgeons, researchers, and multidisciplinary clinicians who want to explore cutting‑edge advances in cancer care
+ Sample video: contact me for sample video
+ Information:
14th Annual Houston Methodist Cancer Symposium – August 14, 2026
Presented by the Houston Methodist Dr. Mary and Ron Neal Cancer Center
This annual symposium, dedicated to the science and clinical care of solid and hematologic malignancies, brings together Houston Methodist scientists and physicians from a broad spectrum of fields, including basic, clinical, and epidemiological research. A wide range of topics will be covered, from innovative translational science to clinical updates with strategies for implementation in current clinical practice. The program will provide education focused on improving patient care, research collaboration and leading medicine.
Target Audience
Physician scientists, practicing oncologists, physician assistants, advanced nurse practitioners, oncology nurses, residents, fellows, medical students, allied health care professionals and clinical research associates will benefit from this course.
Learning Objectives
At the conclusion of this activity, the participant should be able to:
- Discuss the fundamental mechanisms of cellular immunotherapy in hematologic malignancies
- Describe the approved cell therapy options in hematologic malignancies including CAR-T cell
- Identify new cellular therapies in the pipeline for these diseases
The Houston Methodist 14th Annual Cancer Symposium 2026 is best for oncologists, surgeons, researchers, and multidisciplinary clinicians who want to explore cutting‑edge advances in cancer care, from prevention and diagnosis to treatment and survivorship. It emphasizes integrating clinical practice with scientific innovation to improve patient outcomes.
👩⚕️ Target Audience
- Medical oncologists & radiation oncologists seeking updates on therapeutic advances.
- Surgical oncologists & general surgeons involved in cancer treatment.
- Pathologists & radiologists focusing on cancer diagnostics and imaging.
- Primary care physicians & internists managing cancer risk and survivorship.
- Nurse practitioners, physician associates, pharmacists, and oncology nurses working in cancer care teams.
- Researchers & scientists studying cancer biology, immunotherapy, and translational medicine.
- Residents & fellows preparing for careers in oncology or related specialties.
📚 What Participants Gain
- Therapeutic updates: immunotherapy, targeted therapy, precision medicine, and novel agents.
- Diagnostic advances: imaging, pathology, biomarkers, and AI‑driven tools.
- Multidisciplinary strategies: integrating surgery, radiation, and systemic therapy.
- Prevention & survivorship: lifestyle, genetics, and long‑term patient care.
- Scientific frontiers: translational research bridging lab discoveries with clinical practice.
- Case‑based learning: real patient scenarios to sharpen decision‑making.
+ Topics:
- 01 Translational Cancer Research – From Scientific Discovery to Clinical Trials
- 02 Targeting Menin in AML—Clinical Experience and Emerging Strategies With Revumenib, Bleximenib, and Ziftomenib
- 03 Lymphoma Radiation Therapy – Evolving Toward Lower-Dose and Response-Adapted Approaches
- 04 ALK-Positive NSCLC – First-Line Lorlatinib Strategies Informed by 7-Year CROWN Data
- 05 Triple Negative Breast Cancer – ERβ Agonist Strategies to Reprogram the Tumor Microenvironment With Anti–PD-1 Therapy
- 06 Innovations in the Design and Synthesis of Personalized mRNA Cancer Vaccines
- 07 Generation of Safe and Effective Systemic Anti-Tumor Immunity Through an Intratumoral Immunotherapy Delivery System
- 08 Nutrition in Oncology – From Supportive Care to Therapeutic Strategy
- 09 Ovarian Cancer Clinical Updates and Epigenome Targeting From Preclinical Models to the Clinic
Reviews
There are no reviews yet.